Well Referenced

Tag: finasteride

A new look at the 5alpha-reductase inhibitor finasteride

This 2006 review published in CNS Drug Reviews (PMID: 16834758) evaluates the broader pharmacological effects of finasteride, a 5α-reductase inhibitor used to treat benign prostatic hyperplasia and androgenetic alopecia. Beyond reducing dihydrotestosterone (DHT), finasteride alters the metabolism of neuroactive steroids like allopregnanolone, impacting GABAergic neurotransmission. These neurosteroid shifts have been

Read More »
June 26, 2025 No Comments

A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia

This 2018 randomized controlled trial published in the Journal of the European Academy of Dermatology and Venereology (PMID: 29972712) compared the effectiveness and safety of a topical solution combining 0.25% finasteride with 3% minoxidil versus 3% minoxidil alone in men with androgenetic alopecia (AGA). Over 24 weeks, the combination therapy

Read More »
June 26, 2025 No Comments

An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia

This 2004 randomized controlled trial published in Dermatology (PMID: 15316165) compared the efficacy and safety of oral finasteride (1 mg/day) and 5% topical minoxidil in 65 men with androgenetic alopecia over 12 months. The clinical cure rate—measured by increased hair density—was significantly higher in the finasteride group (80%) compared to

Read More »
June 26, 2025 No Comments

Androgenetic alopecia: an evidence-based treatment update

This 2014 systematic review published in the American Journal of Clinical Dermatology (PMID: 24848508) provides an evidence-based update on treatments for androgenetic alopecia (AGA) in both men and women. The review concludes that oral finasteride (1 mg/day) and topical minoxidil (2% or 5%) are the most effective and well-supported options,

Read More »
June 26, 2025 No Comments

Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss)

This randomized controlled trial evaluated the long-term efficacy of finasteride 1 mg/day in preventing further visible hair loss in men with androgenetic alopecia (AGA). Analyzing data from 1,553 participants across two Phase III studies, the results showed that daily finasteride use led to a 93% reduction in the 5-year likelihood

Read More »
June 26, 2025 No Comments